-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Maintains Buy on Chemed, Lowers Price Target to $595

Benzinga·09/10/2025 15:16:50
Listen to the news
B of A Securities analyst Joanna Gajuk maintains Chemed (NYSE:CHE) with a Buy and lowers the price target from $610 to $595.